skip to main content
Idioma:
Refinado por: assunto: Rats, Wistar remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats
Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats
Material Type:
Artigo 		Adicionar ao Meu Espaço

Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats

de Meira Santos Lima, Marcelo ; Braga Reksidler, Angela ; Marques Zanata, Sílvio ; Bueno Machado, Hidevaldo ; Tufik, Sergio ; Vital, Maria A.B.F.

Brain research, 2006-07, Vol.1101 (1), p.117-125 [Periódico revisado por pares]

London: Elsevier B.V

Texto completo disponível

Citações Citado por
2
Repeated intranigral MPTP administration: A new protocol of prolonged locomotor impairment mimicking Parkinson's disease
Repeated intranigral MPTP administration: A new protocol of prolonged locomotor impairment mimicking Parkinson's disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Repeated intranigral MPTP administration: A new protocol of prolonged locomotor impairment mimicking Parkinson's disease

Reksidler, Angela Braga ; Lima, Marcelo Meira Santos ; Dombrowski, Patrícia ; Andersen, Monica Levy ; Zanata, Sílvio Marques ; Andreatini, Roberto ; Tufik, Sergio ; Vital, Maria Aparecida Barbato Frazão

Journal of neuroscience methods, 2008-01, Vol.167 (2), p.268-277 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
3
PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease
PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease

Machado, Meira Maria Forcelini ; Bassani, Taysa Bervian ; Cóppola-Segovia, Valentín ; Moura, Eric Luiz Rossa ; Zanata, Silvio Marques ; Andreatini, Roberto ; Vital, Maria Aparecida Barbato Frazão

Pharmacological reports, 2019-08, Vol.71 (4), p.556-564 [Periódico revisado por pares]

Cham: Elsevier B.V

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.